These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24900193)

  • 1. The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators.
    Huang X; Aslanian R; Zhou W; Zhu X; Qin J; Greenlee W; Zhu Z; Zhang L; Hyde L; Chu I; Cohen-Williams M; Palani A
    ACS Med Chem Lett; 2010 Jul; 1(4):184-7. PubMed ID: 24900193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.
    Zhao Z; Pissarnitski DA; Huang X; Palani A; Zhu Z; Greenlee WJ; Hyde LA; Song L; Terracina G; Zhang L; Parker EM
    ACS Med Chem Lett; 2017 Oct; 8(10):1002-1006. PubMed ID: 29057041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice.
    Rogers K; Felsenstein KM; Hrdlicka L; Tu Z; Albayya F; Lee W; Hopp S; Miller MJ; Spaulding D; Yang Z; Hodgdon H; Nolan S; Wen M; Costa D; Blain JF; Freeman E; De Strooper B; Vulsteke V; Scrocchi L; Zetterberg H; Portelius E; Hutter-Paier B; Havas D; Ahlijanian M; Flood D; Leventhal L; Shapiro G; Patzke H; Chesworth R; Koenig G
    Mol Neurodegener; 2012 Dec; 7():61. PubMed ID: 23249765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a Potent Pyrazolopyridine Series of γ-Secretase Modulators.
    Qin J; Zhou W; Huang X; Dhondi P; Palani A; Aslanian R; Zhu Z; Greenlee W; Cohen-Williams M; Jones N; Hyde L; Zhang L
    ACS Med Chem Lett; 2011 Jun; 2(6):471-6. PubMed ID: 24900332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.
    Bischoff F; Berthelot D; De Cleyn M; Macdonald G; Minne G; Oehlrich D; Pieters S; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter I; Zaja M; Borghys H; Masungi C; Mercken M; Gijsen HJ
    J Med Chem; 2012 Nov; 55(21):9089-106. PubMed ID: 22650177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of BIIB042, a Potent, Selective, and Orally Bioavailable γ-Secretase Modulator.
    Peng H; Talreja T; Xin Z; Cuervo JH; Kumaravel G; Humora MJ; Xu L; Rohde E; Gan L; Jung MY; Shackett MN; Chollate S; Dunah AW; Snodgrass-Belt PA; Arnold HM; Taveras AG; Rhodes KJ; Scannevin RH
    ACS Med Chem Lett; 2011 Oct; 2(10):786-91. PubMed ID: 24900267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators.
    Oehlrich D; Rombouts FJ; Berthelot D; Bischoff FP; De Cleyn MA; Jaroskova L; Macdonald G; Mercken M; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter AI; Wu T; Gijsen HJ
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4794-800. PubMed ID: 23890837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of aminothiazole modulators of the gamma-secretase enzyme.
    Rynearson KD; Buckle RN; Barnes KD; Herr RJ; Mayhew NJ; Paquette WD; Sakwa SA; Nguyen PD; Johnson G; Tanzi RE; Wagner SL
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3928-37. PubMed ID: 27426299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease.
    Huang X; Zhou W; Liu X; Li H; Sun G; Mandal M; Vicarel M; Zhu X; Bennett C; McCraken T; Pissarnitski D; Zhao Z; Cole D; Gallo G; Zhu Z; Palani A; Aslanian R; Clader J; Czarniecki M; Greenlee W; Burnett D; Cohen-Williams M; Hyde L; Song L; Zhang L; Chu I; Buevich A
    ACS Med Chem Lett; 2012 Nov; 3(11):931-5. PubMed ID: 24900409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.
    Chen JJ; Qian W; Biswas K; Yuan C; Amegadzie A; Liu Q; Nixey T; Zhu J; Ncube M; Rzasa RM; Chavez F; Chen N; DeMorin F; Rumfelt S; Tegley CM; Allen JR; Hitchcock S; Hungate R; Bartberger MD; Zalameda L; Liu Y; McCarter JD; Zhang J; Zhu L; Babu-Khan S; Luo Y; Bradley J; Wen PH; Reid DL; Koegler F; Dean C; Hickman D; Correll TL; Williamson T; Wood S
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6447-54. PubMed ID: 24139583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminothiazoles as γ-secretase modulators.
    Lübbers T; Flohr A; Jolidon S; David-Pierson P; Jacobsen H; Ozmen L; Baumann K
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6554-8. PubMed ID: 21924610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.
    Flesch D; Ness J; Lamers C; Dehm F; Popella S; Steri R; Ogorek I; Hieke M; Dannhardt G; Werz O; Weggen S; Schubert-Zsilavecz M
    Bioorg Med Chem Lett; 2015 Feb; 25(4):841-6. PubMed ID: 25575659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-secretase modulation with Abeta42-lowering nonsteroidal anti-inflammatory drugs and derived compounds.
    Czirr E; Weggen S
    Neurodegener Dis; 2006; 3(4-5):298-304. PubMed ID: 17047371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and biological evaluation of imidazopyridine derivatives as a novel scaffold for γ-secretase modulators with oral efficacy against cognitive deficits in Alzheimer's disease model mice.
    Sekioka R; Honda S; Akashiba H; Yarimizu J; Mitani Y; Yamasaki S
    Bioorg Med Chem; 2020 Jun; 28(11):115455. PubMed ID: 32307259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma secretase modulators and BACE inhibitors reduce Aβ production without altering gene expression in Alzheimer's disease iPSC-derived neurons and mice.
    Cusulin C; Wells I; Badillo S; Duran-Pacheco GC; Baumann K; Patsch C
    Mol Cell Neurosci; 2019 Oct; 100():103392. PubMed ID: 31381983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of an aminopiperidine series of γ-secretase modulators.
    Kobayashi T; Iwama S; Fusano A; Kato Y; Ikeda A; Teranishi Y; Nishihara A; Tobe M
    Bioorg Med Chem Lett; 2014 Jan; 24(1):378-81. PubMed ID: 24269163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of gamma-secretase inhibitors and modulators.
    Imbimbo BP
    Curr Top Med Chem; 2008; 8(1):54-61. PubMed ID: 18220933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of Aβ42 reduction in plasma, CSF and brain of rats treated with the γ-secretase modulator, GSM-10h.
    Hawkins J; Harrison DC; Ahmed S; Davis RP; Chapman T; Marshall I; Smith B; Mead TL; Medhurst A; Giblin GM; Hall A; Gonzalez MI; Richardson J; Hussain I
    Neurodegener Dis; 2011; 8(6):455-64. PubMed ID: 21389687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.